Volgende

Automatisch afspelen

Managing Avelumab Side Effects in Patients With Merkel Cell Carcinoma

2 Bekeken • 07/17/23
Delen
insluiten
administrator
administrator
abonnees
0

Howard L. Kaufman, MD, FACS, chief surgical officer and associate director for clinical science at Rutgers Cancer Institute of New Jersey, discusses the adverse event profile of avelumab (Bavencio) for patients with Merkel cell carcinoma.

Laat meer zien
0 Comments sort Sorteer op
Facebook Reacties

Volgende

Automatisch afspelen